日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.

通过不同途径给药的双重改变肽配体对实验性自身免疫性重症肌无力相关反应的主动抑制作用的性质

Paas-Rozner M, Sela M, Mozes E

Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes

修饰肽配体通过抑制由致肌无力T细胞表位诱导的磷脂酶C活性,发挥部分激动剂的作用。

Faber-Elmann, A; Paas-Rozner, M; Sela, M; Mozes, E

Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis

人乙酰胆碱受体α亚基致病表位的肽类似物作为重症肌无力的潜在调节剂

Zisman, E; Katz-Levy, Y; Dayan, M; Kirshner, S L; Paas-Rozner, M; Karni, A; Abramsky, O; Brautbar, C; Fridkin, M; Sela, M; Mozes, E